Clinical Trial Update: Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia [NA]

View source ↗

Summary

Completed clinical trial evaluating a combination chemotherapy regimen for newly diagnosed pediatric acute lymphoblastic leukemia, including the T-cell subtype.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• T-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: T-cell Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia | NA | Status: COMPLETED